- Home
- NXJ vs CYRX Comparison
NXJ vs CYRX Comparison
Compare NXJ & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXJ
- CYRX
- Stock Information
- Founded
- NXJ 1999
- CYRX 1999
- Country
- NXJ United States
- CYRX United States
- Employees
- NXJ N/A
- CYRX N/A
- Industry
- NXJ Finance/Investors Services
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- NXJ Finance
- CYRX Health Care
- Exchange
- NXJ Nasdaq
- CYRX Nasdaq
- Market Cap
- NXJ 457.7M
- CYRX 438.7M
- IPO Year
- NXJ N/A
- CYRX N/A
- Fundamental
- Price
- NXJ $12.28
- CYRX $8.87
- Analyst Decision
- NXJ
- CYRX Strong Buy
- Analyst Count
- NXJ 0
- CYRX 10
- Target Price
- NXJ N/A
- CYRX $11.70
- AVG Volume (30 Days)
- NXJ 74.9K
- CYRX 578.2K
- Earning Date
- NXJ 01-01-0001
- CYRX 11-06-2025
- Dividend Yield
- NXJ 3.27%
- CYRX N/A
- EPS Growth
- NXJ N/A
- CYRX N/A
- EPS
- NXJ N/A
- CYRX 1.35
- Revenue
- NXJ N/A
- CYRX $237,879,000.00
- Revenue This Year
- NXJ N/A
- CYRX N/A
- Revenue Next Year
- NXJ N/A
- CYRX $9.08
- P/E Ratio
- NXJ N/A
- CYRX $6.57
- Revenue Growth
- NXJ N/A
- CYRX 24.93
- 52 Week Low
- NXJ $10.06
- CYRX $4.58
- 52 Week High
- NXJ $12.24
- CYRX $10.46
- Technical
- Relative Strength Index (RSI)
- NXJ 80.24
- CYRX 50.42
- Support Level
- NXJ $12.00
- CYRX $8.53
- Resistance Level
- NXJ $12.25
- CYRX $10.46
- Average True Range (ATR)
- NXJ 0.12
- CYRX 0.58
- MACD
- NXJ 0.07
- CYRX -0.10
- Stochastic Oscillator
- NXJ 94.13
- CYRX 31.76
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.